Neil Carragher
Voorzitter bij The Corporate Partnership Ltd.
Profiel
Neil Carragher is the founder of Pheno Therapeutics Ltd.
which was founded in 2018.
He is currently the Chairman of The Corporate Partnership Ltd.
Mr. Carragher's former positions include Chairman of NUCRYST Pharmaceuticals Corp.
from 2005 to 2010, and Director positions at Agrium, Inc. and The Westaim Corp.
Mr. Carragher's education includes an undergraduate degree from the University of Glasgow and a graduate degree from the University of London.
Actieve functies van Neil Carragher
| Bedrijven | Functie | Begin |
|---|---|---|
| The Corporate Partnership Ltd. | Voorzitter | - |
Eerdere bekende functies van Neil Carragher
| Bedrijven | Functie | Einde |
|---|---|---|
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Voorzitter | 09-02-2010 |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Oprichter | - |
| THE WESTAIM CORPORATION | Directeur/Bestuurslid | - |
| AGRIUM INC | Directeur/Bestuurslid | - |
Opleiding van Neil Carragher
| University of Glasgow | Undergraduate Degree |
| University of London | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| THE WESTAIM CORPORATION | Finance |
| Bedrijven in privébezit | 4 |
|---|---|
Agrium, Inc.
 Agrium, Inc. Chemicals: AgriculturalProcess Industries Agrium, Inc. engages in the production and distribution of agricultural products, services, and solutions. It operates through the Retail and Wholesale segments. The Retail segment offers crop nutrients, crop protection products, seed, merchandise and services. The Wholesale segment produces, markets, and distributes crop nutrients and industrial products. The company was founded on December 21, 1992 and is headquartered in Calgary, Canada | Process Industries |
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
| The Corporate Partnership Ltd. | |
Pheno Therapeutics Ltd.
Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
